AI expert Kevin Novak was no stranger to hype.

The venture capital firm approached Anthropic with an offer to lead a multibillion-dollar investment, according to a person ...

The deal would value the firm at about $2 billion and mark the latest push by private equity into the industry.

After a frenetic first couple of weeks as far as big rounds go, this week was quieter than a library. Only one round of more ...

Discover how shrinking markets are forcing VCs to adapt. Will they stick to local ecosystems or compete globally to retain ...

Reports suggest that markets are projected to bounce back, making 2025 one of the strongest years in recent memory for ...

CNBC's Kate Rooney sits down with Sarah Guo, Conviction Founder, and Mark Goldberg, Chemistry Co-Founder, to discuss their transitions from established firms to founding their own ventures, ...

Arch Capital Group has elevated Prashant Nema to executive vice president and deputy chief operations officer as the company looks to strengthen its operational capabilities and tap into global talent ...

In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...

Discover innovative architecture with Foster + Partners' waterfront towers and transformative projects reshaping cities ...

Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder, according to investors ...

The firm will use the proceeds to advance BE-101 for hemophilia B through clinical proof-of-concept testing and BE-102 for hypophosphatasia into the clinic.